Suvorexant for insomnia in patients with psychiatric disorder: A 1‐week, open‐label study

• Main Authors: Taro Kishi (Author), Kenji Sakuma (Author), Makoto Okuya (Author), Kohei Ninomiya (Author), Kazuto Oya (Author), Momoko Kubo (Author), Yuki Matsui (Author), Ikuo Nomura (Author), Yuji Okuyama (Author), Shinji Matsunaga (Author), Nakao Iwata (Author)
• Format: Book
• Published: Wiley, 2019-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Aim There have been no previous reports on the efficacy and safety of suvorexant for insomnia in people with psychiatric disorders. Methods This one‐week, prospective, single‐arm, clinical trial of fixed dose of suvorexant (20 mg if ages 18-64 or 15 mg if age ≥ 65 years) for insomnia includ...